as 11-22-2024 1:30pm EST
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Founded: | 1984 | Country: | United States |
Employees: | N/A | City: | SAN DIEGO |
Market Cap: | 6.1M | IPO Year: | N/A |
Target Price: | $7.00 | AVG Volume (30 days): | 413.5K |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.70 | EPS Growth: | N/A |
52 Week Low/High: | $0.24 - $2.35 | Next Earning Date: | 11-13-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AEMD Breaking Stock News: Dive into AEMD Ticker-Specific Updates for Smart Investing
Zacks Small Cap Research
8 days ago
Newsfile
8 days ago
GuruFocus.com
8 days ago
PR Newswire
9 days ago
Newsfile
10 days ago
Medical Device Network
11 days ago
MT Newswires
11 days ago
PR Newswire
11 days ago
The information presented on this page, "AEMD Aethlon Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.